Product NDC: | 61703-309 |
Proprietary Name: | VinCRIStine Sulfate |
Non Proprietary Name: | VINCRISTINE SULFATE |
Active Ingredient(s): | 1 mg/mL & nbsp; VINCRISTINE SULFATE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61703-309 |
Labeler Name: | Hospira Worldwide, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA071484 |
Marketing Category: | ANDA |
Start Marketing Date: | 19880419 |
Package NDC: | 61703-309-26 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (61703-309-26) > 1 mL in 1 VIAL, SINGLE-USE |
NDC Code | 61703-309-26 |
Proprietary Name | VinCRIStine Sulfate |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (61703-309-26) > 1 mL in 1 VIAL, SINGLE-USE |
Product NDC | 61703-309 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | VINCRISTINE SULFATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19880419 |
Marketing Category Name | ANDA |
Labeler Name | Hospira Worldwide, Inc. |
Substance Name | VINCRISTINE SULFATE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient] |